经中国证监会浙江证监局查明，海南华铁涉嫌违法的事实如下： 一、公司重大合同临时公告披露不完整（事项一） 2025 年3月3日，公司全资子公司海南华铁大黄蜂建筑机械设备有限公司（以下简称华铁大黄蜂，系 《算力服务协议》乙方）和杭州某公司（系《算力服务协议》甲方）签署《算力服务协议》，预计合同 总金额36.9亿元，其中第2.3条约定"甲方将按照自身需要向乙方不定期的按照采购订单（模板）发出采 购订单。采购订单经甲方发出即生效，双方无需另行签署盖章。采购订单一旦生效，即对双方具有法律 约束力""在订单约定的服务起始日前，如甲方下游客户单方面解除订单，甲方有权随时单方面解除订 单，而无须承担任何责任"。2025年3月5日公司披露《关于子公司签署<算力服务协议>的公告》，但未 披露前述对协议履行有重大影响的条款，公司临时公告披露不完整。 二、公司重大合同重大进展或变化披露不及时（事项二） 登录新浪财经APP 搜索【信披】查看更多考评等级 受损股民可至新浪股民维权平台登记该公司维权：http://wq.finance.sina.com.cn/ 关注@新浪证券、微信关注新浪券商基金、百度搜索新浪股民维权、访问新浪财经客户端 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 受损股民可至新浪股民维权平台登记该公司维权：http://wq.finance.sina.com.cn/ 关注@新浪证券、微信关注新浪券商基金、百度搜索新浪股民维权、访问新浪财经客户端、 新浪财经首页都能找到我们！ 2025年12月27日，西安派瑞功率半导体变流技术股份有限公司（简称：派瑞股份（维权），代码： 300831）发布《关于公司收到中国证券监督管理委员会立案告知书的公告》。称因公司涉嫌信息披露违 法违规，根据《中华人民共和国证券法》《中华人民共和国行政处罚法》等法律法规，中国证监会决定 对公司立案。 根据《民法典》、《证券法》及最高人民法院的关于虚假陈述民事赔偿司法解释的规定，上市公司、控 股股东、实际控制人、董监高人员及其中介机构等因虚假陈述等的证券欺诈行为导致证券投资者权益受 损的，应承担民事赔偿责任，赔偿范围包括：投资差额、佣金、印花税等。权益受损的证券投资者可以 向有管辖权的法院提起民事赔偿诉讼。 由于派瑞股份涉嫌信息披露违法违规，被中国证监会立案调查，为维护证券投资者合法权益，上海汉联 律师事务所宋一欣律师向曾经购买过派瑞股份的证券投资者展 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 受损股民可至新浪股民维权平台登记该公司维权：http://wq.finance.sina.com.cn/ 关注@新浪证券、微信关注新浪券商基金、百度搜索新浪股民维权、访问新浪财经客户端、 新浪财经首页都能找到我们！ 2025年12月27日，浙江臻镭科技（维权）股份有限公司（简称：臻镭科技，代码：688270）发布《关于 收到中国证券监督管理委员会立案告知书的公告》，称因公司涉嫌信息披露违法违规，根据《中华人民 共和国证券法》《中华人民共和国行政处罚法》等法律法规，中国证监会决定对公司予以立案。 根据《民法典》、《证券法》及最高人民法院的关于虚假陈述民事赔偿司法解释的规定，上市公司、控 股股东、实际控制人、董监高人员及其中介机构等因虚假陈述等的证券欺诈行为导致证券投资者权益受 损的，应承担民事赔偿责任，赔偿范围包括：投资差额、佣金、印花税等。权益受损的证券投资者可以 向有管辖权的法院提起民事赔偿诉讼。 由于臻镭科技涉嫌信息披露违法违规，被中国证监会立案调查，为维护证券投资者合法权益，上海汉联 律师事务所宋一欣律师向曾经购买过臻镭科技的证券投资者展开诉讼代理征集， ...

Core Viewpoint - Shanghai Zhuoran Engineering Technology Co., Ltd. (Zhuoran Co., stock code: 688121) is under investigation by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure laws, which may impact investor rights and lead to potential compensation claims [1][2]. Group 1: Regulatory Actions - The CSRC has decided to initiate an investigation against Zhuoran Co. and its actual controller, Zhang Jinhong, due to violations related to information disclosure and improper use of raised funds [1][2]. - Zhuoran Co. is accused of misusing part of the raised funds from its IPO projects, with funds being funneled through accounts controlled by Zhang Jinhong to external pools, violating the regulations of the Information Disclosure Management Measures for Listed Companies [2]. Group 2: Investor Compensation - Investors who purchased Zhuoran Co. stocks or bonds before December 20, 2025, and either sold or continued to hold them after this date may be eligible for compensation claims [3]. - The compensation scope includes investment differences, commissions, and stamp duties, and affected investors can file civil compensation lawsuits based on the CSRC's administrative penalties [2][3]. Group 3: Legal Proceedings - The progress of civil compensation lawsuits may be affected by Zhuoran Co.'s potential delisting or bankruptcy proceedings, which could significantly impact the litigation process [4]. - Investors seeking to register for compensation must provide specific documentation, including identification and securities account information [4].

Core Viewpoint - Guizhou Bailing Pharmaceutical Group Co., Ltd. is facing administrative penalties from the China Securities Regulatory Commission (CSRC) for financial misconduct, including underreporting sales expenses and overstating profits in multiple fiscal years [2][3]. Financial Misconduct Summary - Guizhou Bailing failed to adhere to the accounting standards, resulting in the following discrepancies: - In 2019, sales expenses were understated by 350.12 million yuan, leading to an overstatement of profits by the same amount, which constituted 95.73% of the reported profit for that year [2]. - In 2020, the company understated sales expenses by 240.81 million yuan, resulting in a profit overstatement of 240.81 million yuan, which was 115.35% of the reported profit [2]. - In 2021, sales expenses were understated by 63.79 million yuan, leading to a profit overstatement of 63.79 million yuan, accounting for 45.04% of the reported profit [2]. - In 2023, sales expenses were overstated by 459.41 million yuan, resulting in an understatement of profits by the same amount, which was 93.17% of the reported profit [2]. Legal and Regulatory Actions - The CSRC plans to impose penalties on Guizhou Bailing, its actual controller Jiang Wei, and other responsible personnel, including warnings and fines [2]. - Investors affected by the company's financial misstatements may seek civil compensation for losses incurred due to the misleading information [3]. - A lawyer from Shanghai Hanlian Law Firm is actively recruiting investors who purchased Guizhou Bailing's securities before April 30, 2024, to assist in filing compensation claims [3][4]. Investor Compensation Process - Investors can register for compensation if they bought Guizhou Bailing's stocks or bonds before April 30, 2024, and sold or held them afterward [3]. - Required materials for compensation registration include a copy of the ID, original securities account confirmation, and original transaction records [4].

Core Viewpoint - Shanghai Zhuoran Engineering Technology Co., Ltd. (Zhuoran Co., stock code: 688121) is under investigation by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure laws, leading to administrative measures against the company and its actual controller Zhang Jinhong [1][2]. Group 1: Violations and Investigations - From 2021 to 2024, Zhuoran Co. improperly utilized part of the funds raised during its IPO process, channeling them through accounts controlled by its major shareholder Zhang Jinhong, which violated the regulations of the Information Disclosure Management Measures for Listed Companies [2][6]. - The company failed to accurately disclose the actual use and storage of the raised funds, as well as the non-operational fund transactions with related parties, leading to administrative corrective measures imposed by the Shanghai Securities Regulatory Bureau [2][6]. Group 2: Legal Implications for Investors - Investors who suffered losses due to Zhuoran Co.'s actions can seek civil compensation, which includes investment differences, commissions, and stamp duties, as per the Civil Code and Securities Law [2][6]. - A lawyer from Shanghai Hanlian Law Firm is collecting claims from investors who purchased Zhuoran Co. stocks or bonds before December 20, 2025, and either sold or continued to hold them after that date [3][7]. Group 3: Claim Registration Process - Investors wishing to register for claims must provide specific documents, including a copy of their ID, a securities account confirmation, and transaction records from the date of initial purchase to the present [4][8]. - The conditions for claims may be adjusted based on the conclusions of the CSRC's administrative penalties, and the administrative penalty decision is considered a necessary prerequisite for filing lawsuits [8].

经中国证监会山东证监局查明，朗进科技涉嫌违法的事实如下：2024年2月至2025年7月，朗进科技及其 子公司成都朗进交通装备有限公司、青岛朗进新能源设备有限公司、武汉朗进科技有限公司、长春朗进 交通装备有限公司、青岛朗进数字能源技术有限公司、济南朗进新能源科技有限公司直接或通过第三方 公司与控股股东青岛朗进集团有限公司（以下简称朗进集团）及其子公司莱芜朗进电气有限公司、济南 瑞青科技有限公司发生关联方非经营性资金占用，累计发生额为41，520.63万元。其中，2024年2月至6 月关联方非经营性资金占用发生额为8，648.70万元，截至2024年6月30日，关联方非经营性资金占用余 额为248.70万元，占2024年半年度报告披露净资产的0.28%，朗进科技未及时披露也未在2024年半年度 报告披露上述关联方非经营性资金占用，2024年半年度报告存在重大遗漏；2024年7月至2025年7月关联 方非经营性资金占用发生额为32，871.93万元，朗进科技未及时披露上述关联方非经营性资金占用。截 至2025年8月，朗进集团已偿还上述关联方非经营性资金占用本息。朗进科技2024年年度报告、2025年 半年度报告披露 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 受损股民可至新浪股民维权平台登记该公司维权：http://wq.finance.sina.com.cn/ 关注@新浪证券、微信关注新浪券商基金、百度搜索新浪股民维权、访问新浪财经客户端、 新浪财经首页都能找到我们！ 2025年12月10日，广东惠伦晶体科技股份有限公司（简称：惠伦晶体，代码：300460）发布《关于公司 及相关当事人收到行政处罚事先告知书的公告》。 经中国证监会广东监管局查明，惠伦晶体、赵积清等涉嫌信息披露违法违规的事实如下： 一、惠伦晶体未按规定披露资金占用事项，2020年年度报告存在重大遗漏。2020年，惠伦晶体以采购设 备及材料、预付工程款等名义向东莞市某科技有限公司、东莞市某拆迁有限公司、苏州某实业发展有限 公司、江苏某科技有限公司、天津某有限公司、某（电子）有限公司以及深圳市某有限公司等7家公司 支出款项，并最终划转至控股股东新疆惠伦股权投资合伙企业（有限合伙）（以下简称新疆惠伦）及公 司实际控制人赵积清本人等关联方银行账户，用于归还新疆惠伦股权质押款及赵积清个人借款。上述关 联方非经营性资金往来构成关联方对公司的资金占用，2020年 ...

Group 1 - Tianfeng Securities has been investigated by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure and illegal financing, leading to a formal case being opened against the company [1] - The CSRC's decision is based on the Securities Law and Administrative Penalty Law of the People's Republic of China, which holds the company and its executives liable for any damages caused to investors due to false statements [1] - A lawyer from Shanghai Hanlian Law Firm is collecting claims from investors who purchased Tianfeng Securities before November 29, 2025, and either sold or continued to hold their investments after that date [1] Group 2 - Investors are advised that while they can file lawsuits directly without an administrative penalty decision, doing so may carry risks of losing the case due to limited investigative means [2] - The progress of civil compensation lawsuits may be affected by the company's status, such as whether it is delisted or enters bankruptcy proceedings [2] - Required materials for investors to register or pre-register claims include a copy of their ID, original securities account confirmation, and original transaction records [2]

由于立方数科涉嫌信息披露违法违规，被中国证监会预处罚，为维护证券投资者合法权益，上海汉联律 师事务所宋一欣律师向曾经购买过立方数科的证券投资者展开诉讼代理征集，代理投资者索赔诉讼，权 益受损的证券投资者可以向前述律师进行索赔登记。（宋一欣律师专栏） 登录新浪财经APP 搜索【信披】查看更多考评等级 宋一欣律师认为，立方数科案的索赔条件为：2022年4月25日至2025年4月28日期间买入立方数科股票或 债券等证券市场公开发行产品，并在2025年4月29日及之后卖出或继续持有的受损投资者，可以办理索 赔登记。（立方数科维权入口） 2025年11月29日，立方数科股份有限公司 （简称：立方数科、ST立方（维权），代码：300344）发布 《关于公司及相关人员收到行政处罚及市场禁入事先告知》及重大违法强制退市风险提示的公告》。 经中国证监会安徽证监局查明，立方数科等涉嫌违法的事实如下：立方数科通过开展代理业务、融资性 贸易、虚假贸易虚增营业收入、 营业成本、利润总额，导致立方数科披露的2021年至2023年年度报告 存在虚假记载。其中，2021年，虚增营业收入279，726，668.85元，占当年营业收入的50.0 ...